• 1
    Liggins GC. Parturition in the sheep and the human. Basic Life Sci 1974;4: 423443.
  • 2
    Bassett JM, Thorburn GD. Foetal plasma corticosteroids and the initiation of parturition in sheep. J Endocrinol 1969;44: 285286.
  • 3
    Anderson AB, Flint AP, Turnbull AC. Mechanism of action of glucocorticoids in induction of ovine parturition: effect on placental steroid metabolism. J Endocrinol 1975;66: 6170.
  • 4
    Whittle WL, Patel FA, Alfaidy N, et al. Glucocorticoid regulation of human and ovine parturition: the relationship between fetal hypothalamic–pituitary–adrenal axis activation and intrauterine prostaglandin production. Biol Reprod 2001;64: 10191032.
  • 5
    Sugimoto Y, Yamasaki A, Segi E, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997;277: 681683.
  • 6
    Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 1999;13: 981992.
  • 7
    Minjarez D, Konda V, Word RA. Regulation of uterine 5 alpha-reductase type 1 in mice. Biol Reprod 2001;65: 13781382.
  • 8
    Herbison AE. Physiological roles for the neurosteroid allopregnanolone in the modulation of brain function during pregnancy and parturition. Prog Brain Res 2001;133: 3947.
  • 9
    Honnebier WJ, Swaab DF. The influence of anencephaly upon intrauterine growth of fetus and placenta and upon gestation length. J Obstet Gynaecol Br Commonw 1973;80: 577588.
  • 10
    Bedin M, Fournier T, Mouhadjer N, Pointis G. Incidence of placental sulfatase deficiency on the mode of termination of pregnancy. Gynecol Obstet Invest 1987;24: 8691.
  • 11
    Sanborn BM. Relationship of ion channel activity to control of myometrial calcium. J Soc Gynecol Investig 2000;7: 411.
  • 12
    Kupittayanant S, Luckas MJ, Wray S. Effect of inhibiting the sarcoplasmic reticulum on spontaneous and oxytocin-induced contractions of human myometrium. Br J Obstet Gynaecol 2002;109: 289296.
  • 13
    Word RA, Tang DC, Kamm KE. Activation properties of myosin light chain kinase during contraction/relaxation cycles of tonic and phasic smooth muscles. J Biol Chem 1994;269: 21,59621,602.
  • 14
    Moore F, Da Silva C, Wilde JI, Smarason A, Watson SP, Lopez Bernal A. Up-regulation of p21- and RhoA-activated protein kinases in human pregnant myometrium. Biochem Biophys Res Commun 2000;269: 322326.
  • 15
    Moran CJ, Friel AM, Smith TJ, Cairns M, Morrison JJ. Expression and modulation of Rho kinase in human pregnant myometrium. Mol Hum Reprod 2002;8: 196200.
  • 16
    Vedernikov YP, Syal AS, Okawa T, Jain V, Saade GR, Garfield RE. The role of cyclic nucleotides in the spontaneous contractility and responsiveness to nitric oxide of the rat uterus at midgestation and term. Am J Obstet Gynecol 2000;182: 612619.
  • 17
    Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 2000;279: C1751C1759.
  • 18
    Word RA, Casey ML, Kamm KE, Stull JT. Effects of cGMP on [Ca2+]i, myosin light chain phosphorylation, and contraction in human myometrium. Am J Physiol 1991;260: C861C867.
  • 19
    Europe-Finner GN, Phaneuf S, Tolkovsky AM, Watson SP, Lopez Bernal A. Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab 1994;79: 18351839.
  • 20
    Mehats C, Tanguy B, Paris B, et al. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors. J Pharmacol Exp Ther 2000;292: 817823.
  • 21
    Price SA, Pochun I, Phaneuf S, Lopez Bernal A. Adenylyl cyclase isoforms in pregnant and non-pregnant human myometrium. J Endocrinol 2000;164: 2130.
  • 22
    Steinberg SF, Brunton LL. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 2001;41: 751773.
  • 23
    Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 2000;275: 41,44741,457.
  • 24
    Colledge M, Scott JD. AKAPs: from structure to function. Trends Cell Biol 1999;9: 216221.
  • 25
    Moss SB, Gerton GL. A-kinase anchor proteins in endocrine systems and reproduction. Trends Endocrinol Metab 2001;12: 434440.
  • 26
    Dodge KL, Carr DW, Yue C, Sanborn BM. A role for AKAP (A kinase anchoring protein) scaffolding in the loss of a cyclic adenosine 3′,5′-monophosphate inhibitory response in late pregnant rat myometrium. Mol Endocrinol 1999;13: 19771987.
  • 27
    Keef KD, Hume JR, Zhong J. Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases. Am J Physiol Cell Physiol 2001;281: C1743C1756.
  • 28
    Norwitz ER, Starkey PM, Lopez Bernal A, Turnbull AC. Identification by flow cytometry of the prostaglandin-producing cell populations of term human decidua. J Endocrinol 1991;131: 327334.